BeOne Medicines AG
ONC
$316.99
-$5.38-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.84% | 6.06% | |||
| Total Other Revenue | 25.81% | -- | |||
| Total Revenue | 6.08% | 7.37% | |||
| Cost of Revenue | -27.52% | 19.38% | |||
| Gross Profit | 11.51% | 5.66% | |||
| SG&A Expenses | 4.97% | -1.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.12% | 1.77% | |||
| Operating Income | 13.44% | 85.60% | |||
| Income Before Tax | 1.41% | 47.83% | |||
| Income Tax Expenses | 270.64% | 326.91% | |||
| Earnings from Continuing Operations | -46.73% | 32.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.73% | 32.36% | |||
| EBIT | 13.44% | 85.60% | |||
| EBITDA | 10.37% | 68.88% | |||
| EPS Basic | -46.98% | 30.09% | |||
| Normalized Basic EPS | 17.58% | 53.93% | |||
| EPS Diluted | -49.67% | 33.33% | |||
| Normalized Diluted EPS | 17.25% | 53.94% | |||
| Average Basic Shares Outstanding | 0.47% | 1.75% | |||
| Average Diluted Shares Outstanding | 0.75% | 1.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||